My Company Polska has selected the 25 hottest and best startups – and we’re among them! The stem-cell-based pharmaceuticals, which Bioceltix is developing, are a safer and more effective alternative to traditional chemical-based pharmaceuticals currently on the market. Bioceltix was established in 2016 – with its first funding coming from the StartitFund which is managed by Paweł Wielgus, PhD and Andrij Włach. The company currently employees 12 people. In May of this year, it was recognized at the Start-up Challenge in Katowice. Łukasz Bzdzion’s team was also among the 5 finalists of Chivas Venture.
Puls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO round. So far, the company has obtained a total of approx. PLN 20 million in financing for the development of a still innovative method of treating pets ...
ArticleForbes about Polish start-ups in the coronavirus crisis: “The year 2020 was a big challenge for companies, individual sectors of the economy and probably all of us. In the coming weeks and months of 2021 it will be similar. The condition of start-ups is no exception here. it is easier and ...
ArticleAccording to the „Investors’ Zone”, an interesting year is being prepared on the stock exchange: “This year, an exceptionally large group of companies is choosing NewConnect. As many as 63 companies declared their willingness to enter the alternative market, and several more in the ...
ArticleGazeta Wrocławska wrote about us: “Bioceltix is working on innovative biological medicines used in the treatment of common autoimmune and inflammatory diseases in companion animals. The company from Wrocław has something to fight for. This is indicated by the numbers on the global drug ...
ArticleWe create at Bioceltix veterinary biological medicines, and in 2020 we announced plans for a stock exchange debut and we obtained a permit from the Main Pharmaceutical Inspector to manufacture veterinary biological drugs. Despite the pandemic, we continue our projects without downtime. You can ...
ArticleRzczpospolita: The Wroclaw-based biotech, which is working on breakthrough biopharmaceuticals intended for animals, has received additional ...
Read fullIn the years to come, we are going to see a crop of biotechnology and other projects with global potential. Breakthrough innovations will not ...
Read fullParkiet: Bioceltix has been developing its own pharmaceuticals since 2016. It is also one of the first companies in Europe to complete a full EMA ...
Read full
